Efficacy and Mechanism Evaluation programme - Logo

Efficacy and Mechanism Evaluation Prioritisation Group

Quicklinks
 New funding stream for translational medicine
 Apply for Funding
The researcher-led workstream is currently open for outline applications.  This call will close at 1pm on 17 July 2012.
 Get Involved
Find out how to get involved with our work
 Resources
Useful links, FAQs and information to help with applications
 Join our mailing list
Latest News
 Treating severe fatigue in primary billary cirrhosis
 Lung volume reduction in COPD
 Provisional 2012 Commissioned Research Calls Announced
rss EME News Feed
twitter icon Follow NIHR on Twitter
 

 

Valid XHTML 1.0 Transitional

 

Plain English Campaign

 you are here › HomeAbout EME EME Prioritisation

EME Prioritisation Group

The EME Prioritisation Group supports the EME commissioned workstream. Its purpose is to advise the EME Programme Director on the identification, development and prioritisation of research areas for the commissioned workstream. In addition it prioritises outline proposals received to the EME commissioned workstream and helps shape the development of the EME commissioned workstream. The Prioritisation Group membership comprises senior, experienced clinicians and methodologists who are all active researchers in their field, as well as representation from industry together with patient and public members. It is expected that the Prioritisation Group will meet three times a year.

See the list of current Prioritisation Group Board Members link

 

 

 

 

 

 

 

 

 

 

 

 

 

 printer friendly version   share Share

The Efficacy and Mechanism Evaluation programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland. It is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) based at the University of Southampton.

University of Southampton - Logo